1 / 28

Viruses and Cancer

Viruses and Cancer. Cancers of viral aetiology. Hepatocellular carcinoma (HBV and HCV) Burkitt’s lymphoma (EBV) nasopharyngeal carcinoma (EBV) Hodgkins disease (EBV) cervical carcinoma (HPV) Kaposi’s sarcoma (HHV-8) adult T cell leukaemia/lymphoma (HTLV-1). Criteria. epidemiology

domani
Download Presentation

Viruses and Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Viruses and Cancer

  2. Cancers of viral aetiology • Hepatocellular carcinoma (HBV and HCV) • Burkitt’s lymphoma (EBV) • nasopharyngeal carcinoma (EBV) • Hodgkins disease (EBV) • cervical carcinoma (HPV) • Kaposi’s sarcoma (HHV-8) • adult T cell leukaemia/lymphoma (HTLV-1)

  3. Criteria • epidemiology • virus in tumour tissue • viral genes and oncogenesis

  4. Mechanisms of Oncogenesis • modulation of cell cycle control (The virus may alter the regulatory mechanisms controlling the progress of the cell cycle and cell division) • modulation of apoptosis (the virus must prevent the host cell from undergoing apoptosis, a normal cellular response to viral-induced injury, which would otherwise abort the further development of uncontrolled cell proliferation) • ROS (Reactive oxygen species) mediated damage

  5. Cell Cycle Control • pRB ( a tumor suppressorprotein that is dysfunctional in several major cancers. One function of pRb is to prevent excessive cell growth by inhibiting cell cycle progression until a cell is ready to divide) • cyclin D1 (cell cycle control)

  6. Modulation of Apoptosis • P53 (transcription factor activated by DNA damage that can induce growth arrest and apoptosis) • Bcl-2 (supress apoptosis) • FLICE inhibitory proteins (FLIPs) (inhibit apoptosis signalling)

  7. ROS Damage • inflammatory responses generate radicals, including OH. and NO. • free radicals target DNA (mutation) protein (nitration, nitrosation) RNA lipids (lipid peroxidation)

  8. ROS Damage Free radicals may promote cancer by • mutating cancer related genes • activating signal transduction pathways • promoting angiogenesis • exerting selective pressure (p53 and NO.)

  9. Hepatocellular Carcinoma

  10. Hepatocellular Carcinoma • HCC is one of the most prevalent malignant diseases in the world • chronic infection with HBV or HCV accounts for more than 80% of HCC cases • other risk factors include aflatoxin B1, heavy alcohol consumption and smoking

  11. HCC and HBV • insertional activation • HBx transactivation of proinflammatory genes interaction with p53 • generation of ROS

  12. HCC and HCV • HCV sequences are present in HCC tissue • HCV antigen expression in HCC (or other tissue) cannot be assessed • HCV contains genes with potential oncogenic function

  13. HCV genes HCV core protein has been shown to • cause HCC in transgenic mice • modulate apoptosis • drive cells to proliferation • generate ROS

  14. HCC and hepatitis viruses • mass vaccination against HBV will radically reduce the incidence of HCC in SE Asia • elimination of HCV or HBV reduces the risk of developing HCC

  15. Human Herpesvirus 8 and Kaposi’s Sarcoma

  16. Kaposi’s Sarcoma • Kaposi’s sarcoma (KS) is a mesenchymal tumour involving blood and lymphatic vessels • KS occurs in three forms: classical endemic epidemic

  17. Pathology of KS • Multicentric lesions composed of interweaving bands of spindle cells that form irregular vascular channels • Spindle cells express markers of endothelial cells (CD34 and Factor VIII)

  18. KS and HIV • The incidence of KS in HIV positive gay men is 20,000 fold that of the general population • KS is 20 times more common in homosexual men with AIDS than other risk groups • the risk of KS in HIV positive men increases with the frequency and risk of sexual activity

  19. Herpesviruses and KS • In 1994 RDA isolated viral sequences from KS tissue • these sequences were identified as a new herpesvirus, designated HHV-8 • HHV-8 has now been found in almost 100% of tissues from all forms of KS

  20. Epidemiology • HHV-8 seropositivity in various populations is correlated with the population risk of KS • Longtitudinal surveys have shown infection with HHV-8 precedes the onset of KS

  21. Virus and Tumour Tissue • In individuals with KS, HHV-8 sequences are found in tumour but not in adjacent tissue • within KS lesions, HHV-8 DNA and antigen expression is localised to spindle cells

  22. Genes and oncogenesis HHV-8 encodes homologues of human proteins (examples): • cyclin D1 • G-protein coupled receptor • bcl-2 • FLICE inhibitory protein • And others

  23. v-cyclin D1 • HHV-8 v-cyclin is expressed in KS lesions and interacts with CDK6 • v-cyclin in complex with CDK6 is not inhibited by p16 INK4a or p27Kip1

  24. HHV-8 (G protein-coupled receptor) GPCR • HHV-8 encodes a viral G protein-coupled receptor (vGPCR). • v-GPCR is homologous to the IL-8 receptor • v-GPCR has been shown to transform cells and tumour formation.

  25. HHV-8 bcl-2 • the viral protein has both sequence and structural homology to bcl-2 family proteins • v-bcl-2 is functional • the role of v-bcl-2 in the viral life cycle is not yet clear

  26. v-FLIP • v-FLIPs inhibit apoptosis signalling through death receptors • HHV-8 v-FLIP physically interacts with pro-caspase-8 and prevents recruitment to DISC

  27. Non-homologous Viral Genes • Latency -associated nuclear antigen (LANA) is essential to the maintenance of HHV-8 • LANA interacts with p53 and suppresses its transcriptional activity

More Related